|
| Rheumatoid arthritis: biologics useful in young and old alike A new study presented at the 2019 ACR/ARP Annual Meeting says that all rheumatoid arthritis (RA) patients, irrespective of their age, benefit to a similar extent from the use of biologic drugs in their treatment. The study measured improvement in disease parameters 48 weeks after the beginning of therapy to establish this conclusion. | |
|
| Steroid injections for osteoarthritis more may damage joints Osteoarthritis (OA), also called degenerative joint disease, is the most common chronic condition of the joints. Since the disease is degenerative, it is the single most common cause of disability among older adults, with about 10 to 15 percent of all adults who are more than 60 years old have some degree of osteoarthritis, with more women affected than men. | |
|
| Methotrexate reduces joint damage in hand osteoarthritis A new study presented at the 2019 ACR/ARP meeting shows that methotrexate stopped further damage to the hand joints and even perhaps improved bone remodeling in patients with osteoarthritis (OA) of the hand, when they were assessed at 3 and 12 months. | |
|
| Rheumatoid arthritis linked to other diseases, finds new study A study led by the Mayo Clinic published in Mayo Clinic Proceedings, found that the risk of developing rheumatoid arthritis (RA) is higher in people with type 1 diabetes, blood clotting disorders, or inflammatory bowel disease. | |
|
| People with osteoarthritis at higher risk of social isolation Osteoarthritis (OA) is a degenerative disease of the joints, often leading to disability. In older adults with osteoarthritis, they may have problems with mobility, walking, and even doing simple activities due to severe pain, reduced flexibility, and joint swelling. | |
|
|
|
No hay comentarios:
Publicar un comentario